Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canada. [electronic resource]
Producer: 20020312Description: 1824-38; discussion 1791 p. digitalISSN:- 0149-2918
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.